Solid Biosciences (SLDB) stock retains a "Strong Buy" rating, driven by robust interim data for SGT-003 in pediatric Duchenne ...
Sonos has long been the multi-room king, but in recent years its position has become a little shaky. Not only is it under threat from cheaper alternatives like the Amazon Echo range, but also from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results